AGTX — Agentix Corp.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1603345 ·
Last close
$0.02
Market Cap
$681.1K
52W High
$0.04
52W Low
$0.02
ADV30
12,960
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | — | -67,463 | -78,595 | 6,396 | 6,396 | 3,504,396 |
| Sep 2025 | 0 | — | -123,097 | -144,107 | 5,601 | 5,601 | 3,423,639 |
| Jun 2025 | 0 | — | -200,342 | -185,824 | 4,412 | 4,412 | 3,276,178 |
| Mar 2025 | 0 | — | -172,121 | -181,768 | 100,274 | 4,477 | 3,204,523 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-166,363
Investing CF
$0
Financing CF
$155,450
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,930,054
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-517,210
Pretax Income TTM
$-590,294
Interest Exp TTM
$73,084
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 0 | -513,251 | -567,048 | 100,274 | 3,204,523 | — | -125,078 |
| Mar 2024 | 0 | -744,810 | -585,154 | 106,372 | 2,666,594 | — | -110,429 |
| Mar 2023 | 0 | -1,371,756 | -1,373,805 | 261,392 | 2,510,555 | — | -88,541 |
| Aug 2021 | 1,240 | -1,340,352 | -1,340,347 | 51,207 | 606,942 | — | -420,982 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| WINT | WINDTREE THERAPEUTICS INC /DE/ | $482.0K | $0.01 | — |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | $455.6K | $0.01 | — |
| ABPO | Abpro Holdings, Inc. | $1.15M | $0.19 | — |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.74M | $0.34 | — |
| GPLB | Green Planet Bio Engineering Co. Ltd. | $260.1K | $0.01 | — |
Recent Insider Activity
No insider activity indexed for this ticker.